Skip to content
Drug recall · FDA · Published January 7, 2020

Preferred Pharmaceuticals, Inc recalls Preferred Pharmaceuticals, Inc, Ranitidine Tablets, 300 mg, Rx Only, a) 14 count bottles (NDC: 68788-6382-1), b) 30

Preferred Pharmaceuticals recalls ranitidine tablets due to NDMA impurity detected in product. This recall affects specific bottle sizes and lot numbers.

🇺🇸 FDA recall #D-0797-2020DrugPreferred Pharmaceuticals ›
Take action

Contact the company & request your remedy

Recalling firmPreferred Pharmaceuticals, Inc1250 N Lakeview Ave Ste O · Anaheim, CA 92807-1801
No email on file for this recall — reach the company by phone or its official page instead.No email on file — write to the address above instead.
✎ GovInfoNow plain-language explainer

What happened, in plain English

Preferred Pharmaceuticals is recalling ranitidine tablets (300 mg, Rx Only) because they contain NDMA impurity. This impurity has been detected in the product and may pose health risks. Read more at govinfonow.com/recall/37486-preferred-pharmaceuticals-recalls-ranitidine-tablets-with-ndma-impurity.

Source Summary by GovInfoNow · govinfonow.com/recall/37486-preferred-pharmaceuticals-recalls-ranitidine-tablets-with-ndma-impurity · Updated October 5, 2026 · FDA enforcement record: FDA #D-0797-2020

Cite this page

“Preferred Pharmaceuticals recalls ranitidine tablets with NDMA impurity.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/37486-preferred-pharmaceuticals-recalls-ranitidine-tablets-with-ndma-impurity. Based on FDA recall #D-0797-2020 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0797-2020%22&limit=1).

Why it’s dangerous

NDMA (N-nitrosodimethylamine) is a potential carcinogen that can form in some medications. The presence of this impurity in ranitidine tablets may increase cancer risk over time with use.

Who’s affected

People who have the recalled ranitidine tablets (14-count, 30-count, 90-count, or 100-count bottles) are affected. Those using prescription ranitidine for conditions like ulcers are most at risk.

How to tell if you have this one

Check for ranitidine tablets labeled 300 mg, Rx Only, with bottle sizes of 14, 30, 90, or 100 counts. The NDC codes are 68788-6382-1, 68788-6382-3, 68788-6382-9, or 68788-6382-0.

  • Brand
    Preferred Pharmaceuticals
  • Category
    Drug
FDA recall event · 2 products

All 2 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Terminated
  • Distribution
    Distribution to physicians in the following states: AL, AZ, CA, FL, GA, IN, and SC
Recall numberProduct, codes & lotsQuantity
D-0796-2020Preferred Pharmaceuticals, Inc, Ranitidine Tablets, 150 mg, a) 30 count bottles (NDC: 68788-7388-3), b) 60 count bottles (NDC: 68788-7388-6), c) 90 count bottles (NDC: 68788-7388-9), d) 100 count bottles (NDC: 68788-7388-1); Lot #: All lots within expiry221,710 tablets
D-0797-2020Preferred Pharmaceuticals, Inc, Ranitidine Tablets, 300 mg, Rx Only, a) 14 count bottles (NDC: 68788-6382-1), b) 30 count bottles (NDC: 68788-6382-3), c) 90 count bottles (NDC: 68788-6382-9), d) 100 count bottles (NDC: 68788-6382-0); Lot #: All lots within expiry39,172 tablets
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Look for the bottle size and NDC code on the product label to confirm if it is recalled.

✎ GovInfoNow

Questions people ask

Is this product safe to use?

The recall states that NDMA impurity was detected in the product, but the official notice does not specify if it is safe to use.

What should I do if I have the recalled product?

The recall notice does not provide specific action steps for affected individuals.

How can I confirm if my product is recalled?

Check the product label for the bottle size and NDC code to see if it matches the recalled items listed.

Take action

Contact Preferred Pharmaceuticals

We’ve drafted a message you can send Preferred Pharmaceuticals to request your refund or repair — edit it as you like.

Subject: Recall D-0797-2020 — Preferred Pharmaceuticals Preferred Pharmaceuticals

Hello,

I own a Preferred Pharmaceuticals that is covered by recall D-0797-2020 from Preferred Pharmaceuticals.

I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this?

Thank you.

Similar recalls

Keep exploring

From people who’ve dealt with this

Experiences, tips, and questions from readers. Every comment is reviewed before it appears.

No comments yet — be the first to share your experience.

Comments are reviewed before they appear. No links, ads, or personal attacks — those get removed.

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0797-2020 (January 7, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0797-2020 to see it in context.
  • Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA